TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Bio Forte AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
9,323
|
9,970
|
10,999 |
Financial expenses |
5
![]() |
5
![]() |
5 |
Earnings before taxes |
326
|
279
|
696 |
Total assets |
3,081
|
3,045
|
3,032 |
Current assets |
2,860
|
2,687
|
2,853 |
Current liabilities |
850
|
936
|
1,033 |
Equity capital |
2,231
|
2,106
|
1,994 |
- share capital |
133
|
141
|
149 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.4%
|
69.2%
|
65.8% |
Turnover per employee | |||
Profit as a percentage of turnover |
3.5%
|
2.8%
|
6.3% |
Return on assets (ROA) |
10.7%
|
9.3%
|
23.1% |
Current ratio |
336.5%
|
287.1%
|
276.2% |
Return on equity (ROE) |
14.6%
|
13.2%
|
34.9% |
Change turnover |
-34
|
-451
|
-1,244 |
Change turnover % |
0%
|
-4%
|
-10% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.